|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.86 USD | -27.31% |
|
-.--% | - |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Performance
| 1 day | -27.31% | ||
| 3 years | +28.89% | ||
| 5 years | -2.82% |
Volumes
marketsDaily volume
200
Estimated daily volume
200
Record volume 1
2,509
Record volume 2
938
Record volume 3
815
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
3,349,767,808
Net sales (EUR)
743,483,000
Net sales (USD)
849,630,068
Number of employees
1,998
Sales / Employee (EUR)
372,114
Sales / Employee (USD)
425,240
Free-Float
31.63 %
Free-Float capitalization (USD)
1,061,464,735
Indicators
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -27.31% | -.--% | -.--% | +28.89% | 3.35B | |
| +1.86% | +8.65% | +56.45% | +158.84% | 1,063B | |
| +3.57% | +9.15% | +68.70% | +58.92% | 611B | |
| +3.99% | +11.15% | +37.41% | +93.77% | 444B | |
| -1.20% | -0.96% | +26.12% | +20.22% | 324B | |
| +4.94% | +4.51% | +39.76% | +28.93% | 285B | |
| +2.42% | +2.96% | +30.77% | +42.24% | 283B | |
| +2.47% | +6.56% | -24.26% | -39.60% | 219B | |
| +3.55% | +6.47% | +28.79% | +68.52% | 195B | |
| +4.21% | +4.88% | +17.49% | +70.33% | 156B | |
| Average | -1.40% | +2.83% | +28.12% | +53.11% | 358.4B | |
| Weighted average by Cap. | +0.23% | +4.16% | +41.90% | +80.63% |
Historical Quotes: Laboratorios Farmaceuticos Rovi, S.A.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 3 years | 50.88 |  | 90.61 |
| 5 years | 0.03 | | 90.61 |
| 10 years | 0.03 | | 90.61 |
Monthly variations
Annual variations
| 2024 | +26.66% | ||
| 2023 | +1.76% | ||
| 2022 | -25.67% | ||
| 2021 | +26.03% |
- Stock Market
- Stocks
- ROVI Stock
- LABFF Stock
- Quotes Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
